X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6843) 6843
Book Review (1674) 1674
Publication (339) 339
Conference Proceeding (119) 119
Newsletter (57) 57
Magazine Article (45) 45
Book Chapter (38) 38
Trade Publication Article (11) 11
Newspaper Article (10) 10
Dissertation (2) 2
Book / eBook (1) 1
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
dabigatran (5414) 5414
index medicus (4453) 4453
humans (4319) 4319
warfarin (3120) 3120
rivaroxaban (2689) 2689
anticoagulants (2387) 2387
atrial fibrillation (2277) 2277
anticoagulants - therapeutic use (1771) 1771
apixaban (1762) 1762
male (1718) 1718
stroke (1617) 1617
female (1582) 1582
administration, oral (1498) 1498
dabigatran etexilate (1497) 1497
aged (1463) 1463
atrial fibrillation - drug therapy (1372) 1372
cardiac & cardiovascular systems (1341) 1341
anticoagulants - adverse effects (1320) 1320
anticoagulants - administration & dosage (1300) 1300
peripheral vascular disease (1152) 1152
stroke - prevention & control (1138) 1138
atrial-fibrillation (1079) 1079
hematology (1059) 1059
prevention (1059) 1059
beta-alanine - analogs & derivatives (1045) 1045
middle aged (978) 978
venous thromboembolism (966) 966
atrial fibrillation - complications (964) 964
hemorrhage - chemically induced (960) 960
risk factors (934) 934
benzimidazoles - therapeutic use (855) 855
treatment outcome (847) 847
thromboembolism (809) 809
management (803) 803
medicine, general & internal (798) 798
anticoagulation (782) 782
pharmacology & pharmacy (761) 761
aged, 80 and over (748) 748
safety (734) 734
risk (730) 730
warfarin - therapeutic use (728) 728
stroke prevention (711) 711
therapy (684) 684
oral anticoagulants (662) 662
abridged index medicus (640) 640
benzimidazoles - adverse effects (631) 631
thrombin (631) 631
stroke - etiology (614) 614
bleeding (587) 587
direct thrombin inhibitor (565) 565
beta-alanine - therapeutic use (563) 563
drug therapy (543) 543
analysis (538) 538
hemorrhage (527) 527
dabigatran - therapeutic use (525) 525
benzimidazoles - administration & dosage (523) 523
pyridones - therapeutic use (523) 523
pyrazoles - therapeutic use (521) 521
cardiac arrhythmia (520) 520
care and treatment (517) 517
antithrombins - therapeutic use (511) 511
medicine & public health (491) 491
antithrombins - adverse effects (485) 485
edoxaban (478) 478
warfarin - adverse effects (478) 478
beta-alanine - adverse effects (462) 462
dabigatran - adverse effects (446) 446
efficacy (444) 444
blood coagulation - drug effects (441) 441
thrombosis (439) 439
dosage and administration (430) 430
pyridines - therapeutic use (425) 425
vitamin k - antagonists & inhibitors (418) 418
pharmacokinetics (403) 403
surgery (400) 400
cardiology (398) 398
direct oral anticoagulants (391) 391
thiophenes - therapeutic use (389) 389
morpholines - therapeutic use (388) 388
retrospective studies (388) 388
dabigatran - administration & dosage (384) 384
patients (384) 384
metaanalysis (378) 378
adult (377) 377
warfarin - administration & dosage (376) 376
thromboembolism - prevention & control (370) 370
antithrombotic therapy (369) 369
antithrombins - administration & dosage (368) 368
mortality (367) 367
reversal (363) 363
venous thromboembolism - prevention & control (359) 359
enoxaparin (356) 356
risk assessment (353) 353
beta-alanine - administration & dosage (350) 350
internal medicine (344) 344
double-blind (340) 340
factor xa inhibitors (340) 340
pyrazoles - administration & dosage (329) 329
aspirin (328) 328
pyridones - administration & dosage (328) 328
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6074) 6074
German (276) 276
Spanish (193) 193
French (190) 190
Russian (85) 85
Japanese (43) 43
Czech (42) 42
Portuguese (25) 25
Polish (24) 24
Italian (23) 23
Hungarian (22) 22
Swedish (13) 13
Danish (12) 12
Turkish (10) 10
Chinese (5) 5
Dutch (5) 5
Slovenian (5) 5
Finnish (4) 4
Korean (4) 4
Norwegian (4) 4
Croatian (2) 2
Slovak (2) 2
Estonian (1) 1
Persian (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BLOOD, ISSN 0006-4971, 09/2014, Volume 124, Issue 12, pp. 1968 - 1975
In the last 4 years, 6 phase 3 trials including a total of 27 023 patients with venous thromboembolism (VTE) compared a direct oral anticoagulant (DOAC) with... 
DABIGATRAN | METAANALYSIS | EFFICACY | WARFARIN | SAFETY | RIVAROXABAN | HEMATOLOGY
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 5, pp. 431 - 441
Journal Article
by Yip, L and Deng, JF
AMERICAN JOURNAL OF KIDNEY DISEASES, ISSN 0272-6386, 01/2018, Volume 71, Issue 1, pp. 146 - 146
Journal Article
BLOOD, ISSN 0006-4971, 10/2017, Volume 130, Issue 15, pp. 1706 - 1712
There is uncertainty regarding the effectiveness and occurrence of thromboembolic events in patients treated with prothrombin complex concentrates (PCCs) for... 
ANTICOAGULANT | ORAL RIVAROXABAN | DABIGATRAN | HEMATOLOGY | WARFARIN | REVERSAL
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 16, pp. 1513 - 1524
In this trial, dabigatran plus a P2Y 12 inhibitor was compared with warfarin plus a P2Y 12 inhibitor and aspirin after PCI in patients with atrial... 
MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | HEART-DISEASE | MYOCARDIAL-INFARCTION | ORAL ANTICOAGULATION | 2011 ACCF/AHA/SCAI GUIDELINE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | TRIPLE THERAPY | ANTIPLATELET THERAPY | CONSENSUS DOCUMENT | Dabigatran - adverse effects | Ticlopidine - therapeutic use | Humans | Middle Aged | Warfarin - adverse effects | Male | Risk | Dabigatran - therapeutic use | Incidence | Warfarin - therapeutic use | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Therapy, Combination - adverse effects | Adenosine - adverse effects | Adenosine - therapeutic use | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Purinergic P2Y Receptor Antagonists - therapeutic use | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Atrial Fibrillation - therapy | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Adenosine - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention | Warfarin | Atrial fibrillation | Dosage and administration | Research | Thromboembolism | Hemorrhage | Health aspects | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Embolisms | Preventive medicine | Thrombosis | Bleeding | Embolism | Fibrillation | Cardiology | Drug therapy | Drug dosages | Geriatrics | Index Medicus | Abridged Index Medicus | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2017, Volume 376, Issue 17, pp. 1627 - 1636
Journal Article
Journal Article
Medical Care, ISSN 0025-7079, 2018, Volume 56, Issue 5, pp. 410 - 415
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2015, Volume 128, Issue 12, pp. 1300 - 1305.e2
Journal Article
Journal Article